Latest News & Features
Biotechnology
LSIPR spoke to Dr Claire Skentelbery of the ENABLE project about the need for novel developments and the importance of a solid intellectual property strategy. 7 June 2016
Africa
For something to be innovative it must “add value” and companies must ensure they understand the term in order to succeed, the 2016 BIO International Convention has heard. 7 June 2016
Americas
The 2016 BIO International Convention has heard that drug companies are on a mission to discover new tools to support the development of anti-infectives due to a decrease in the development of new antibiotics. 7 June 2016
Americas
The 2016 BIO International Convention kicked off in style Monday night with an evening of scientific discovery at the Exploratorium. 7 June 2016
Big Pharma
EPO case law suggests that inventions covering homeopathic medicines do not have to meet a higher bar of patentability than conventional medicaments, but it still must be shown that the claimed products lead to the alleged therapeutic effect. André Guder of Uexküll & Stolberg reports. 7 June 2016
Americas
Applicants wishing to extend their patents’ term of protection do not have to necessarily match up the wording of the claims and the label of the relevant drug for there to be infringement by an ANDA, as MaryAnne Armstrong of Birch, Stewart, Kolasch & Birch reports. 7 June 2016
Americas
Pharmaceutical company AstraZeneca has agreed a licensing deal with German drug maker Grünenthal centring on gout treatment drug Zurampic. 6 June 2016
Big Pharma
Europe is not providing an adequate level of patent protection to the medical device industry, and while a solution exists, legislators need to be brave enough to abandon convention and adopt it, argue Reuben Jacob and Fiona Kellas of Jenkins. 6 June 2016
Asia
Over the past few years there have been a number of IP developments in the pharma and biotech industries in Japan, including on patent term extension and product-by-process claims. Osamu Yamamoto of Yuasa and Hara provides a roundup. 6 June 2016
article
More than 15,000 life sciences industry professionals will arrive in San Francisco for the 2016 BIO International Convention from June 6 to 9. LSIPR highlights some of the most interesting sessions 6 June 2016